ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
dachopper
|
554 |
202K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
554
|
202K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
dachopper
|
554 |
202K |
19 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
554
|
202K
|
19
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
dachopper
|
554 |
202K |
16 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
554
|
202K
|
16
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Approves Sofdra
|
|
dachopper
|
554 |
202K |
13 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
554
|
202K
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
dachopper
|
390 |
137K |
13 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
390
|
137K
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
dachopper
|
390 |
137K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
390
|
137K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
dachopper
|
390 |
137K |
30 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
390
|
137K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
dachopper
|
199 |
74K |
11 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
199
|
74K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
dachopper
|
390 |
137K |
18 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
390
|
137K
|
18
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
dachopper
|
390 |
137K |
41 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
390
|
137K
|
41
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
dachopper
|
390 |
137K |
4 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
390
|
137K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
32 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
282
|
106K
|
32
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
21 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
282
|
106K
|
21
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
22 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
282
|
106K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dachopper
|
1.0K |
439K |
7 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
1.0K
|
439K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
8 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
282
|
106K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
31 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
282
|
106K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
dachopper
|
225 |
84K |
23 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
225
|
84K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
dachopper
|
225 |
84K |
7 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
225
|
84K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dachopper
|
1.0K |
439K |
14 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
1.0K
|
439K
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
32 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
282
|
106K
|
32
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
4 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
282
|
106K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
8 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
282
|
106K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
16 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
282
|
106K
|
16
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
dachopper
|
10K |
3.8M |
12 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
10K
|
3.8M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
dachopper
|
10K |
3.8M |
6 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
10K
|
3.8M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
dachopper
|
10K |
3.8M |
7 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
10K
|
3.8M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
23 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
282
|
106K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dachopper
|
1.0K |
439K |
8 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
439K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
5 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
282
|
106K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
3 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
282
|
106K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
47 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
282
|
106K
|
47
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
dachopper
|
943 |
407K |
9 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
943
|
407K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
25 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
282
|
106K
|
25
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
6 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
282
|
106K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
dachopper
|
943 |
407K |
4 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
943
|
407K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Sofdra US Sales Curve
|
|
dachopper
|
48 |
27K |
18 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
48
|
27K
|
18
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Final Sofdra Labelling Discussions with FDA
|
|
dachopper
|
282 |
106K |
12 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
282
|
106K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
dachopper
|
14K |
5.2M |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
14K
|
5.2M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
dachopper
|
225 |
84K |
18 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
225
|
84K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
dachopper
|
943 |
407K |
33 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
943
|
407K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
dachopper
|
1.0K |
439K |
13 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
1.0K
|
439K
|
13
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
dachopper
|
10K |
3.8M |
20 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
10K
|
3.8M
|
20
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
dachopper
|
10K |
3.8M |
6 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
10K
|
3.8M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
dachopper
|
225 |
84K |
12 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
225
|
84K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
dachopper
|
14K |
5.2M |
13 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
14K
|
5.2M
|
13
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
dachopper
|
14K |
5.2M |
8 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
14K
|
5.2M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
dachopper
|
10K |
3.8M |
15 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
10K
|
3.8M
|
15
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
dachopper
|
10K |
3.8M |
12 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
10K
|
3.8M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
dachopper
|
10K |
3.8M |
13 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
10K
|
3.8M
|
13
|
|